James Trott
Co-founder & Executive Director — Life Sciences recruitment
Summary
Work
Writing
The opportunity and the bottleneck. Where talent really matters in AI driven drug discovery
January 19, 2026Argues that, as AI becomes integral to drug discovery, the primary constraint is hybrid scientific talent (biology + ML) rather than capital or compute, and outlines hiring risks and strategic priorities for founders.
Biotech, TechBio, and what this means for hiring in 2026
December 10, 2025Explores distinctions between biotech and TechBio, and explains how positioning determines hiring needs—arguing for early investment in hybrid leadership and embedding ML/data roles within R&D.
Is France becoming Europe’s answer to Silicon Valley for TechBio and MedTech?
October 29, 2025Analyzes France's emerging TechBio and MedTech ecosystem, comparing regional strengths and arguing France offers integrated science and engineering advantages for early-stage companies.
From big tech to biotech: why AI and ML talent is migrating to Life Sciences
July 9, 2025Examines the trend of AI/ML professionals leaving large tech firms for life sciences roles driven by purpose, impact and product scope, and advises startups on attracting this talent.
How AI and machine learning are reshaping careers in Life Sciences
March 26, 2025Discusses how AI/ML are changing hiring needs and role definitions across biotech, MedTech and pharma, emphasizing hybrid skills and hiring for potential over fixed CV requirements.